TAVI in 2016: the year the treatment of aortic stenosis was transformed
Chairpersons: G. GEROSA, S. WINDECKER
Objectives:
To learn from the latest evidence in the field of TAVITo understand which patient populations would either benefit from surgical aortic valve replacement or TAVI
To learn how the TAVI procedure can be further streamlined with new generation delivery systems and valves
Lectures
Session objectives
G. Gerosa
TAVI in 2016: what is the data that justifies transformational change?
M. Gilard
When should surgical aortic valve replacement still be considered in intermediate risk patients?
V. Falk
Recorded case from St. Thomas’ Hospital - London, United Kingdom
S. Windecker
LIVE demonstration from St. Thomas’ Hospital - London, United Kingdom
Optimising the in-hospital patient pathway
J. Reinöhl
Optimising TAVI through technological innovation
S. Windecker